Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_assertion type Assertion NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_head.
- NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_assertion description "[Interferon-associated type 1 diabetes is characterized clinically by high titers of GAD65 antibodies and preserved ?-cell function, and genetically by addition of HLA-A*2402to DRB1*1302-DQA1*0102-DQB1*0604.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_provenance.
- NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_assertion evidence source_evidence_literature NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_provenance.
- NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_assertion SIO_000772 21270202 NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_provenance.
- NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_assertion wasDerivedFrom befree-2016 NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_provenance.
- NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_assertion wasGeneratedBy ECO_0000203 NP868014.RA02Hlorue-7P-OyypuDf3Lc8z96yHqLbddSJt5kmGQVc130_provenance.